PMID- 11500038 OWN - NLM STAT- MEDLINE DCOM- 20010920 LR - 20131121 IS - 0006-291X (Print) IS - 0006-291X (Linking) VI - 286 IP - 2 DP - 2001 Aug 17 TI - Direct observation of release of cytochrome c from lipid-encapsulated protein by peroxide and superoxide: a possible mechanism for drug-induced apoptosis. PG - 311-4 AB - Release of cytochrome c from inside lipid vesicles and from inside proteoliposomes formed by cytochrome c oxidase has been studied by spectrophotometric methods. The protein encapsulated inside vesicles did not form complex with sodium azide solution added externally. Both hydrogen peroxide and superoxide were found to cause release of cytochrome c from the lipid encapsulated protein, which was detected from the distinct spectral changes due to the formation of the azide complex of cytochrome c in the solution. Cytochrome c encapsulated inside proteoliposomes containing cytochrome c oxidase (CcO) did not release the cytochrome c during enzymatic turnover of CcO. The anticancer drug, doxorubicin, was found to inhibit the biochemical function of cytochrome c oxidase and release of cytochrome c was observed from the proteoliposome encapsulating the protein during the enzymatic turnover in the presence of doxorubicin. The results indicated that the inhibition of enzymatic activity by doxorubicin possibly leads to the formation of reactive oxygen species, which induce the release of cytochrome c from inside to outside of the membrane. CI - Copyright 2001 Academic Press. FAU - Das, N AU - Das N AD - Department of Chemical Sciences, Tata Institute of Fundamental Research, Homi Bhabha Road, Mambai, 400005, India. FAU - Gupta, S AU - Gupta S FAU - Mazumdar, S AU - Mazumdar S LA - eng PT - Journal Article PL - United States TA - Biochem Biophys Res Commun JT - Biochemical and biophysical research communications JID - 0372516 RN - 0 (Cytochrome c Group) RN - 0 (Liposomes) RN - 0 (Proteolipids) RN - 0 (proteoliposomes) RN - 11062-77-4 (Superoxides) RN - 12030-88-5 (potassium superoxide) RN - 80168379AG (Doxorubicin) RN - BBX060AN9V (Hydrogen Peroxide) RN - EC 1.9.3.1 (Electron Transport Complex IV) SB - IM MH - *Apoptosis MH - Cytochrome c Group/*metabolism MH - Doxorubicin/pharmacology MH - Electron Transport Complex IV/metabolism MH - Hydrogen Peroxide/*pharmacology MH - Liposomes/metabolism MH - Proteolipids/metabolism MH - Superoxides/*pharmacology EDAT- 2001/08/14 10:00 MHDA- 2001/09/21 10:01 CRDT- 2001/08/14 10:00 PHST- 2001/08/14 10:00 [pubmed] PHST- 2001/09/21 10:01 [medline] PHST- 2001/08/14 10:00 [entrez] AID - S0006-291X(01)95403-8 [pii] AID - 10.1006/bbrc.2001.5403 [doi] PST - ppublish SO - Biochem Biophys Res Commun. 2001 Aug 17;286(2):311-4. doi: 10.1006/bbrc.2001.5403.